Business
Cuentas Extends Expiration Date of its Publicly Traded Warrants From February 4, 2026 to June 30, 2026
Cuentas Extends Expiration Date of its Publicly Traded Warrants From February 4, 2026 to June 30, 2026.
About this update from Cuentas Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Cuentas Extends Expiration Date of its Publicly Traded Warrants From February 4, 2026 to June 30, 2026\r\n \r\n \r\n\r\n\r\nCuentas Extends Expiration Date of its Publicly Traded Warrants From February 4, 2026 to June 30, 2026\r\n\r\n\r\n\r\n\r\n\r\nMIAMI BEACH, FL, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Cuentas, Inc. (OTCID: CUEN & CUENW) (“Cuentas”) Cuentas, Inc. (the “Company”) today announced that it had extended the expiration date of its publicly traded warrants (OTCID: CUENW) (the “Warrants”) from February 4, 2026 to June 30, 2026. The Warrants were issued and sold by the Company on February 4, 2021 as part of a firm commitment public offering of its units, consisting of one share of its common stock, par value $0.001 per share (“Common Stock”), and a warrant to purchase an additional share of Common Stock exercisable for five years at an exercise price of $4.30 per share (the “Warrants”). The Company sold an aggregate of 2,790,697 units at a price to the public of $4.30 per unit in the offering. The Common Stock and the Warrants were offered and sold to the public pursuant to the Company’s registration statements on Form S-1 (File Nos. 333-249690 and 333-252642), filed by the Company with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), on October 28, 2020, as amended, and which became effective on February 1, 2021. The Company received gross proceeds of approximately $12.0 million, before deducting underwriting discounts and commissions of 8% of the gross proceeds and estimated offering expenses, In July 2021, Warrants to purchase an aggregate of 1,451,500 shares of Common Stock were exercised resulting in gross proceeds to the Company of $6,241,450. On March 24, 2023, the Company completed a 1-for-13 reverse stock split of its Common Stock. As a result of the reverse stock split, (i) every thirteen shares of Common Stock were combined into one share of Common Stock; and (ii) the number of shares of Common Stock underlying each Warrant was proportionately decreased on a 1-for-13 basis, and the exercise price of each such outstanding Warrant was proportionately increased on a 1-for-13 basis to $55.90 per share.  The Company is extending the expiration...